Gynecologic Cancer News

Self-identifying transgender individuals assigned female at birth face three key barriers when seeking care for breast or gynecologic cancers, according to results of a qualitative study published in JAMA Network Open.

Adults with Graves’ disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid.

September is Gynecologic Cancer Awareness Month.

Despite the incidence of endometrial cancer diagnosis increasing annually, several promising approaches for treatment and diagnosis of endometrial cancer have been approved or are in development.

The FDA has missed its action date to address its proposed rule banning formaldehyde and formaldehyde-releasing chemicals from hair smoothing and straightening products.

The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.

Ovarian cancer care costs are considerable, varying by care phase, age and geographic region, with the highest costs observed at initiation of and end-of-life care, researchers reported in the American Journal of Obstetrics and Gynecology.

The addition of pembrolizumab to adjuvant chemotherapy improved DFS for certain women with newly diagnosed high-risk endometrial cancer, according to randomized phase 3 study results presented at ESMO Congress.

The combination of pembrolizumab and chemoradiotherapy significantly improved OS for women with high-risk locally advanced cervical cancer, according to results of a randomized phase 3 trial presented at ESMO Congress.

Genital talc powder and frequent douching were associated with an increased risk for ovarian cancer, according to a recent study.